How promiscuity promotes tolerance: The case of myasthenia gravis

Annals of the New York Academy of Sciences

Volumn 1132, Issue , 2008, Pages 157-162

  Kyewski, Bruno ^a   Taubert, Richard ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Autoimmune regulator; Central tolerance; Promiscuous gene expression; Thymic epithelial cells

Indexed keywords

AUTOANTIGEN; AUTOIMMUNE REGULATOR PROTEIN; CHOLINERGIC RECEPTOR; INSULIN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN;

ANTIGEN EXPRESSION; CONFERENCE PAPER; DISEASE COURSE; EPITHELIUM CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; MYASTHENIA GRAVIS; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; THYMUS; TRANSCRIPTION REGULATION; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 45249124322     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1405.026     Document Type: Conference Paper

References (30)

1. Kyewski, B. & J. Derbinski. 2004. Self-representation in the thymus: an extended view. Nat. Rev. Immunol. 4 : 688 698.
2. Kyewski, B. & L. Klein. 2006. A central role for central tolerance. Annu. Rev. Immunol. 24 : 571 606.
3. Peterson, P. & L. Peltonen. 2005. Autoimmune polyendocrinopathy syndrome type 1 (APS1) and AIRE gene: new views on molecular basis of autoimmunity. J. Autoimmun. 25 (Suppl 49 55.
4. DeVoss, J.J. & M.S. Anderson. 2007. Lessons on immune tolerance from the monogenic disease APS1. Curr. Opin. Genet. Dev. 17 : 193 200.
5. DeVoss, J. et al. 2006. Spontaneous autoimmunity prevented by thymic expression of a single self-antigen. J. Exp. Med. 203 : 2727 2735.
6. Gavanescu, I. et al. 2007. Loss of Aire-dependent thymic expression of a peripheral tissue antigen renders it a target of autoimmunity. Proc. Natl. Acad. Sci. USA 104 : 4583 4587.
7. Liston, A. et al. 2003. Aire regulates negative selection of organ-specific T cells. Nat. Immunol. 4 : 350 354.
8. Aschenbrenner, K. et al. 2007. Selection of Foxp3(+) regulatory T cells specific for self antigen expressed and presented by Aire(+) medullary thymic epithelial cells. Nat. Immunol. 8 : 351 358.
9. Derbinski, J. et al. 2005. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J. Exp. Med. 202 : 33 45.
10. Anderson, M.S. et al. 2002. Projection of an immunological self shadow within the thymus by the aire protein. Science 298 : 1395 1401.
11. Wekerle, H. & U.P. Ketelsen. 1977. Intrathymic pathogenesis and dual genetic control of myasthenia gravis. Lancet 1 : 678 680.
12. Schluep, M. et al. 1987. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study. Ann. Neurol. 22 : 212 222.
13. Taubert, R., J. Schwendemann & B. Kyewski. 2007. Highly variable expression of tissue-restricted self-antigens in human thymus: implications for self-tolerance and autoimmunity. Eur. J. Immunol. 37 : 838 848.
14. Giraud, M. et al. 2007. An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus. Nature 448 : 934 937.
15. Geuder, K.I. et al. 1992. Pathogenetic significance of fetal-type acetylcholine receptors on thymic myoid cells in myasthenia gravis. Dev. Immunol. 2 : 69 75.
16. Bruno, R. et al. 2004. Different patterns of nicotinic acetylcholine receptor subunit transcription in human thymus. J. Neuroimmunol. 149 : 147 159.
17. Navaneetham, D. et al. 2001. Human thymuses express incomplete sets of muscle acetylcholine receptor subunit transcripts that seldom include the delta subunit. Muscle Nerve 24 : 203 210.
18. Klein, L., B. Roettinger & B. Kyewski. 2001. Sampling of complementing self-antigen pools by thymic stromal cells maximizes the scope of central T cell tolerance. Eur. J. Immunol. 31 : 2476 2486.
19. Leite, M.I. et al. 2007. Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status. Am. J. Pathol. 171 : 893 905.
20. Holmdahl, R. 2007. Aire-ing self antigen variability and tolerance. Eur. J. Immunol. 37 : 598 601.
21. Liston, A. et al. 2005. Genetic lesions in T-cell tolerance and thresholds for autoimmunity. Immunol. Rev. 204 : 87 101.
22. Chentoufi, A.A. & C. Polychronakos. 2002. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 51 : 1383 1390.
23. Thebault-Baumont, K. et al. 2003. Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J. Clin. Invest. 111 : 851 857.
24. Pugliese, A. et al. 1997. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat. Genet. 15 : 293 297.
25. Vafiadis, P. et al. 1997. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet. 15 : 289 292.
26. Lew, A., W.J. Rutter & G.C. Kennedy. 2000. Unusual DNA structure of the diabetes susceptibility locus IDDM2 and its effect on transcription by the insulin promoter factor Pur-1/MAZ. Proc. Natl. Acad. Sci. USA 97 : 12508 12512.
27. Todd, J.A. et al. 2007. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 39 : 857 864.
28. Haas, J. et al. 2005. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 35 : 3343 3352.
29. Baecher-Allan, C. & D.A. Hafler. 2006. Human regulatory T cells and their role in autoimmune disease. Immunol. Rev. 212 : 203 216.
30. Bluestone, J.A. et al. 2007. What does the future hold for cell-based tolerogenic therapy? Nat. Rev. Immunol. 7 : 650 654.